At ACPMP’s 2022 annual symposium, Dr. Laura Lambert moderates part 2 of the general session. This video covers new research and innovative technology for PMP patients and it ends with a Q&A with experts.
Carol Higgins Clark, New York Times best-selling mystery author and daughter of author Mary Higgins Clark, was diagnosed with Stage 4 appendix cancer in late 2020. Appendix cancer is a rare and severe disease, which can be very challenging to treat as it is often discovered after the tumor has burst through the appendix spreading cancer cells throughout the abdomen. This is the case with Carol, made more difficult because she has one of the more aggressive types: goblet cell with signet ring cell features. Due to the aggressive behavior of Carol’s cancer and the disease burden already present at the time of discovery, she was advised that any treatment would likely have limited effect in prolonging her life for any significant time.
Dr. Garrett Nash from Memorial Sloan Kettering (MSK) in New York City presents: “Clinical Trials for Metastatic Appendix Cancer: How We Can Learn to Better Care for Patients with this Disease”. This educational webinar was co-hosted by the ACPMP Research Foundation and patient advocate, Chrissy Buttigieg. Topics covered during this webinar included: What is the risk and benefit of CRS? What is EPIC and how does it differ from HIPEC? Does IPC improve outcomes? What is the current standing of the ICARuS trial? Q&A
Dr. Grotz, Surgical Oncologist from the Mayo Clinic presented: Mucinous Appendiceal Cancers: from Appendectomy to HIPEC.
The webinar was co-hosted by the ACPMP Research Foundation and Minnesota’s Patient Advisory Council members, Meghan Blomquist and Angel Harrington who lead the MN Appendix Cancer Allies.
This event was held via Zoom on October 27, 2021 and was free and open to all.
Dr. Edward Levine, Chief of Surgical Oncology, Wake Forest presented “Appendix Cancer, an Introduction” at the Appendix Cancer Survivorship Symposium on October 15, 2021.
Dr. Laura Lambert, Professor of Surgery and Director of the Peritoneal Malignancy Program at Huntsman Cancer Institute presented “Updates: Papers of the year for Appendiceal Cancer” at the Appendix Cancer Survivorship Symposium on October 15, 2021.
Dr. Kiran Turaga, Associate Professor of Surgery and Director of the Regional Therapeutics Program at University of Chicago presented “Implications of Ongoing Research in the Treatment of Appendix Cancer” at the Appendix Cancer Survivorship Symposium on October 15, 2021.
Lauren Smith, Development and Communications Manager, ACPMP Research Foundation presented “Patient Advisory Council and ACPMP Overview” at the Appendix Cancer Survivorship Symposium on October 15, 2021.
Dr. Ardaman Shergill, Oncologist, U Chicago presented “Chemotherapy for Appendix Cancer, The Old and New” at the Appendix Cancer Survivorship Symposium on October 15, 2021.
Dr. Kostas Votanopoulos, Professor of Surgery, Wake Forest presented “Organoids to personalize chemotherapy” at the Appendix Cancer Survivorship Symposium on October 15, 2021.
Dr. Mustafa Raoof, Surgical Oncologist and Assistant Clinical Professor, City of Hope Medical Center presented “PIPAC: Current US Perspective” at the Appendix Cancer Survivorship Symposium on October 15, 2021.
Dr. Chuan He, University of Chicago – John T. Wilson Distinguished Service Professor in the Department of Chemistry and Department of Biochemistry and Molecular Biology presented “Liquid Biopsy for detection of hard to detect cancers” at the Appendix Cancer Survivorship Symposium on October 15, 2021.
(833) 227-6773 
info@acpmp.org 
751 Sproul Road #1057, Springfield, PA 19064